Skip to content
POM-V Prescription Required Companion Animal

Purevax RCP Lyophilisate and Solvent for Suspension for Injection

Active ingredients: Feline calicivirus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Form

Injection

Species

Cats

Manufacturer

Boehringer Ingelheim Vetmedica GmbH

VMD MA No.

04491/5053

What it's used for

Active immunisation of cats aged 8 weeks and older: - - - Onset of immunity: 1 week after primary vaccination course. Duration of immunity: 1 year after th...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Feline calicivirus + Feline...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Purevax RCP Lyophilisate and Solvent for Suspension for Injection — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Active immunisation of cats aged 8 weeks and older:
-
-
-
Onset of immunity: 1 week after primary vaccination course.
Duration of immunity: 1 year after the primary vaccination course and 3 years
after the last re-vaccination.

Revised: December 2024
AN: 02039/2024
None.
Cats:
Common
(1 to 10 animals / 100 animals treated):
Apathy, anorexia, and hyperthermia.
Injection site reactions (pain, itching,
oedema).
Uncommon
(1 to 10 animals / 1 000 animals treated):
Hypersensitivity reaction.
Very rare
(<1 animal / 10 000 animals treated,
including isolated reports):
Emesis.
1
lasting usually for 1 or 2 days.
slight pain at palpation, itching or limited oedema disappearing within 1 or 2
weeks at most.
may require appropriate symptomatic treatment.
mostly within 24 to 48 hours.
Reporting adverse events is important. It allows continuous safety monitoring of
a veterinary medicinal product. Reports should be sent, preferably via a
veterinarian, to either the marketing authorisation holder, or its local
representative, or the national competent authority via the national reporting
system. See also section “Contact details” of the package leaflet details.

Revised: December 2024
AN: 02039/2024
Vaccinate healthy animals only.

Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
In case of accidental self-injection, seek medical advice immediately and show
the package leaflet or the label to the physician.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.
Safety and efficacy data are available which demonstrate that this vaccine can
be mixed and administered with Boehringer Ingelheim non-adjuvanted vaccine
against feline leukaemia and/or administered the same day but not mixed with
Boehringer Ingelheim adjuvanted vaccine against rabies.
Safety and efficacy data are available which demonstrate that this vaccine can
be mixed and administered with Boehringer Ingelheim non-adjuvanted vaccine
against rabies.
No information is available on the safety and efficacy of this vaccine when used
with any other veterinary medicinal product except the products mentioned
above. A decision to use this vaccine before or after any other veterinary
medicinal product therefore needs to be made on a case-by-case basis.
Store and transport refrigerated (2 C – 8 C).
Protect from light.
Do not freeze.
Not applicable.
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: immunologicals for felidae, cat, live and
inactivated viral vaccines, live feline rhinotracheitis virus + live feline
panleucopenia virus / parvovirus + inactivated feline calicivirus antigen.
ATCvet code: QI06AH09
Vaccine against feline viral rhinotracheitis, feline calicivirosis and feline
panleucopenia.
Stimulates active immunity against feline rhinotracheitis virus, feline calicivirus,
and feline panleucopenia virus.
The veterinary medicinal product was shown to reduce excretion of feline
calicivirus at onset of immunity and for one year after vaccination.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.